Journal of Molecular and Cellular Cardiology
Volume 47, Issue 2 , Pages 210-220 , August 2009

Impact of glucose concentration on cardiac ventricular repolarization under IKr/IKs blocking agents

  • Raymond Hreiche

      Affiliations

    • Faculté de Pharmacie, Université de Montréal, Montréal QC, Canada
    • Centre de Recherche du CHUM, Pavillon Hôtel-Dieu de Montréal, Montréal QC, Canada
    • ,
  • Isabelle Plante

      Affiliations

    • Faculté de Pharmacie, Université de Montréal, Montréal QC, Canada
    • Centre de Recherche du CHUM, Pavillon Hôtel-Dieu de Montréal, Montréal QC, Canada
    • ,
  • Louis-Philippe David

      Affiliations

    • Centre de Recherche du CHUM, Pavillon Hôtel-Dieu de Montréal, Montréal QC, Canada
    • ,
  • Chantale Simard

      Affiliations

    • Faculté de Pharmacie, Université Laval, Québec QC, Canada
    • Hôpital Laval, Centre de Recherche, Québec QC, Canada
    • ,
  • Jacques Turgeon

      Affiliations

    • Faculté de Pharmacie, Université de Montréal, Montréal QC, Canada
    • Centre de Recherche du CHUM, Pavillon Hôtel-Dieu de Montréal, Montréal QC, Canada
    • ,
  • Benoit Drolet

      Affiliations

    • Faculté de Pharmacie, Université Laval, Québec QC, Canada
    • Hôpital Laval, Centre de Recherche, Québec QC, Canada
    • Corresponding Author InformationCorresponding author. Hôpital Laval, Centre de Recherche, 2725, Chemin Sainte-Foy Québec QC, Canada G1V 4G5. Tel.: +1 418 656 8711x5755; fax: +1 418 656 4509.

Received 15 October 2008 ,Revised 21 January 2009 ,Accepted 5 February 2009.

References 

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
  2. Suys BE, Huybrechts SJ, De Wolf D, Op DB, Matthys D, Van Overmeire B, et al. QTc interval prolongation and QTc dispersion in children and adolescents with type 1 diabetes. J. Pediatr. 2002;141(1):59–63
  3. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J. Cardiovasc. Risk. 2001;8(4):227–233
  4. Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'Errico N, et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J. Intern. Med. 2002;251(4):317–324
  5. Borra M, Veglio M, Bruno G. Prevalence of QTc prolongation in type II diabetics: an Italian population-based cohort. (Abstract) Diabetologia. 1999;42(Suppl. 1):A295
  6. Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52(6):1469–1474
  7. Eckert B, Agardh CD. Hypoglycaemia leads to an increased QT interval in normal men. Clin. Physiol. 1998;18(6):570–575
  8. Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia. 2000;43(5):571–575
  9. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation. 1995;91(10):2591–2595
  10. Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34(3):182–185
  11. Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 2002;105(16):1943–1948
  12. Nishizaki M, Ashikaga T, Yamawake N, Fujii H, Arita M, Sumitomo N, et al. Effects of glucose-induced insulin secretion on ventricular repolarization in patients with congenital long QT syndrome. Circ. J. 2002;66(1):35–40
  13. Roden DM. Long QT syndrome: reduced repolarization reserve and the genetic link. J. Intern. Med. 2006;259(1):59–69
  14. Iacobellis G, Curione M, Di Bona S, Ribaudo MC, Zappaterreno A, Vecci E, et al. Effect of acute hyperinsulinemia on ventricular repolarization in uncomplicated obesity. Int. J. Cardiol. 2005;99(1):161–163
  15. Ewing DJ, Neilson JM. QT interval length and diabetic autonomic neuropathy. Diabet. Med. 1990;7(1):23–26
  16. Chambers JB, Sampson MJ, Sprigings DC, Jackson G. QT prolongation on the electrocardiogram in diabetic autonomic neuropathy. Diabet. Med. 1990;7(2):105–110
  17. Lo SS, Sutton MS, Leslie RD. Information on type 1 diabetes mellitus and QT interval from identical twins. Am. J. Cardiol. 1993;72(3):305–309
  18. Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z. Impairment of human ether-a-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J. Biol. Chem. 2003;278(12):10417–10426
  19. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am. Heart J. 2007;153(6):891–899
  20. Fiset C, Drolet B, Hamelin BA, Turgeon J. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. J. Pharmacol. Exp. Ther. 1997;283(1):148–156
  21. Geelen P, Drolet B, Lessard E, Gilbert P, O'Hara GE, Turgeon J. Concomitant block of the rapid (I(Kr)) and slow (I(Ks)) components of the delayed rectifier potassium current is associated with additional drug effects on lengthening of cardiac repolarization. J. Cardiovasc. Pharmacol. Ther. 1999;4(3):143–150
  22. Zhang Y, Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. 2001;40(3):159–168
  23. Patel NH, Rothenberg ML. Multidrug resistance in cancer chemotherapy. Invest. New Drugs. 1994;12(1):1–13
  24. Meissner K, Sperker B, Karsten C, Zu Schwabedissen HM, Seeland U, Bohm M, et al. Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy. J. Histochem. Cytochem. 2002;50(10):1351–1356
  25. Meissner K, Jedlitschky G, Meyer zu SH, Dazert P, Eckel L, Vogelgesang S, et al. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics. 2004;14(6):381–385
  26. Solbach TF, Konig J, Fromm MF, Zolk O. ATP-binding cassette transporters in the heart. Trends Cardiovasc. Med. 2006;16(1):7–15
  27. Oswald S, Grube M, Siegmund W, Kroemer HK. Transporter-mediated uptake into cellular compartments. Xenobiotica. 2007;37(10–11):1171–1195
  28. Dofetilide (Tikosyntm) monograph. Pfizer. 2008.
  29. Walker DK, Alabaster CT, Congrave GS, Hargreaves MB, Hyland R, Jones BC, et al. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data. Drug Metab. Dispos. 1996;24(4):447–455
  30. Gow JM, Chinn LW, Kroetz DL. The effects of ABCB1 3′-untranslated region variants on mRNA stability. Drug Metab. Dispos. 2008;36(1):10–15
  31. Lees-Miller JP, Duan Y, Teng GQ, Duff HJ. Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. Mol. Pharmacol. 2000;57(2):367–374
  32. Sanguinetti MC, Chen J, Fernandez D, Kamiya K, Mitcheson J, Sanchez-Chapula JA. Physicochemical basis for binding and voltage-dependent block of hERG channels by structurally diverse drugs. Novartis Found. Symp. 2005;266:159–166
  33. Hreiche R, Ricard G, Turgeon J, Drolet B. Modulatory effects of glucose concentrations on cardiac repolarization under conditions of drug-induced blockade of IKr and/or IKs currents in guinea pigs. (Abstract) Clin. Pharmacol. Ther. 2007;81(Suppl. 1):S48–S49
  34. Couture L, Nash J, Nguyen L, Turgeon J. Effects of verapamil pre-treatment on the distribution of a p-glycoprotein substrate, 3H-domperidone, in heart and whole-body tissues of Hartley guinea pigs. (Abstract) Clin. Pharmacol. Ther. 2006;79(Suppl. 1):P80
  35. Couture L, Nash J, Nguyen L, Turgeon J. Effects of verapamil pre-treatments on the distribution of 3H-domperidone, a p-glycoprotein substrate, to the heart and other tissues of male and female Hartley guinea pigs. (Abstract) Clin. Pharmacol. Ther. 2007;81(Suppl. 1):S91
  36. Wallace DC. A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. Symp. 2001;235:247–263
  37. Lu T, He T, Katusic ZS, Lee HC. Molecular mechanisms mediating inhibition of human large conductance Ca2+-activated K+ channels by high glucose. Circ. Res. 2006;99(6):607–616
  38. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 2004;279(44):45935–45941
  39. Cai Y, Lu J, Miao Z, Lin L, Ding J. Reactive oxygen species contribute to cell killing and p-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol. Ther. 2007;6(11):1794–1799
  40. Wartenberg M, Ling FC, Schallenberg M, Baumer AT, Petrat K, Hescheler J, et al. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species. J. Biol. Chem. 2001;276(20):17420–17428
  41. Wartenberg M, Hoffmann E, Schwindt H, Grunheck F, Petros J, Arnold JR, et al. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett. 2005;579(20):4541–4549
  42. MacCarthy PA, Grieve DJ, Li JM, Dunster C, Kelly FJ, Shah AM. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation. 2001;104(24):2967–2974
  43. Morissette P, Hreiche R, Turgeon J. Modulatory role of verapamil treatment on the cardiac electrophysiological effects of cisapride. Can. J. Physiol. Pharmacol. 2006;84(12):1285–1290
  44. Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation. 2000;102(16):1883–1885
  45. Plante I, Hreiche R, Bélanger F, Turgeon J. P-glycoprotein (MDR1) expression modulates IC50 of domperidone for block of the rapid component of the delayed rectifier potassium current (IKr) in a HEK293 cell line stably expressing HERG. (Abstract) Clin. Pharmacol. Ther. 2008;83(Suppl. 1):S83–S84
  46. Zhang S, Zhou Z, Gong Q, Makielski JC, January CT. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ. Res. 1999;84(9):989–998
  47. Shimoni Y, Ewart HS, Severson D. Type I and II models of diabetes produce different modifications of K+ currents in rat heart: role of insulin. J. Physiol. 1998;507(Pt 2):485–496
  48. Shimoni Y, Chuang M, Abel ED, Severson DL. Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J. Physiol. 2004;555(Pt 2):345–354
  49. Lengyel C, Virag L, Biro T, Jost N, Magyar J, Biliczki P, et al. Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Cardiovasc. Res. 2007;73(3):512–520
  50. Lengyel C, Virag L, Kovacs PP, Kristof A, Pacher P, Kocsis E, et al. Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart. Acta Physiol. (Oxf.). 2008;192(3):359–368
  51. Zhang Y, Xiao J, Lin H, Luo X, Wang H, Bai Y, et al. Ionic mechanisms underlying abnormal QT prolongation and the associated arrhythmias in diabetic rabbits: a role of rapid delayed rectifier K+ current. Cell. Physiol. Biochem. 2007;19(5–6):225–238

PII: S0022-2828(09)00057-1

doi: 10.1016/j.yjmcc.2009.02.004

Journal of Molecular and Cellular Cardiology
Volume 47, Issue 2 , Pages 210-220 , August 2009

Article Tools

* Image Usage & Resolution